These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera. Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552 [No Abstract] [Full Text] [Related]
23. Experimental myasthenia gravis: isolation and quantitative assay of anti-acetylcholine receptor antibody protein concentration in sera of rabbits immunized with Narke acetylcholine receptor. Ueno S; Kang J; Takeuchi H; Takahashi M; Tarui S Exp Neurol; 1980 Jun; 68(3):512-20. PubMed ID: 7379895 [No Abstract] [Full Text] [Related]
24. Is experimental autoimmune myasthenia gravis induced only by acetylcholine receptors? Claudio TR; Raftery MA J Immunol; 1980 Mar; 124(3):1130-40. PubMed ID: 6153670 [TBL] [Abstract][Full Text] [Related]
25. Anti-presynaptic membrane receptor antibodies in myasthenia gravis. Lu CZ; Link H; Mo XA; Xiao BG; Zhang YL; Qin Z J Neurol Sci; 1991 Mar; 102(1):39-45. PubMed ID: 1856731 [TBL] [Abstract][Full Text] [Related]
26. The use of hybridomas to analyse autoimmunity. Isenberg DA; Shoenfeld Y; Schwartz RS Br Med Bull; 1984 Jul; 40(3):262-6. PubMed ID: 6380637 [No Abstract] [Full Text] [Related]
27. Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis. Lindstrom J; Einarson B Muscle Nerve; 1979; 2(3):173-9. PubMed ID: 503104 [TBL] [Abstract][Full Text] [Related]
28. Antibodies to acetylcholine receptors as probes of receptor structure and pathological agents in myasthenia gravis. Lindstrom J Prog Clin Biol Res; 1981; 63():419-28. PubMed ID: 6171828 [No Abstract] [Full Text] [Related]
29. Antireceptor or antihormone autoimmunity and its relationship with the idiotype network. Bach JF Adv Nephrol Necker Hosp; 1987; 16():251-80. PubMed ID: 3028089 [No Abstract] [Full Text] [Related]
30. Experimental autoimmune myasthenia gravis: the rabbit as an animal model. Eldefrawi ME Fed Proc; 1978 Dec; 37(14):2823-7. PubMed ID: 720635 [TBL] [Abstract][Full Text] [Related]
31. Myasthenia gravis: an example of receptor disease. Conti-Tronconi BM; Fumagalli G; Scotti A; Brigonzi A; Sher E; Morgutti M; Clementi F Adv Biochem Psychopharmacol; 1980; 21():473-88. PubMed ID: 7376974 [No Abstract] [Full Text] [Related]
32. [Myasthenia gravis in newborn infants--pathological mechanism, clinical symptomatology and therapeutic procedures]. Krauze M; Musialik E; Swietliński J; Litwa K; Latko E; Górny J; Sobczyk J Wiad Lek; 1992 Aug; 45(15-16):610-4. PubMed ID: 1488831 [TBL] [Abstract][Full Text] [Related]
33. Agrin-induced aggregation of acetylcholine receptors in muscles of rats with experimental autoimmune myasthenia gravis. Rimer M Ann N Y Acad Sci; 1998 May; 841():546-9. PubMed ID: 9668292 [No Abstract] [Full Text] [Related]
34. A role of alpha-fetoprotein in autoimmune diseases. Abramsky O; Brenner T Ann N Y Acad Sci; 1983; 417():108-16. PubMed ID: 6200026 [No Abstract] [Full Text] [Related]
35. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis. Pachner AR; Kantor FS Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071 [TBL] [Abstract][Full Text] [Related]
38. Effect of sera from myasthenia gravis patients and of alpha-bungarotoxin on acetylcholinesterase during in vitro neuromuscular synaptogenesis. de la Porte S; Ragueh F; Eymard B; Courbin P; Chapron J; Koenig J J Neurol Sci; 1993 Jul; 117(1-2):92-102. PubMed ID: 8410074 [TBL] [Abstract][Full Text] [Related]